Literature DB >> 2677529

Primary central nervous system lymphoma.

B P O'Neill1, J J Illig.   

Abstract

Primary central nervous system lymphomas constitute less than 2% of primary brain tumors. Although their cause is unknown, they are in some way related to immunosuppression. The typical patient is a middle-aged man who displays the syndrome of a subacute mass lesion. These tumors most commonly occur as a single, bulky mass in the hemispheric white matter or the deep gray matter, but multiple tumors occur in approximately a fourth of the patients. The findings on computed tomography are distinctive and nearly pathognomonic. The majority of these tumors are B-cell lymphomas with aggressive histologic changes. Surgical intervention should be reserved for tissue diagnosis because surgical removal does not seem to influence the outcome. Conventional therapy consists of whole-brain irradiation with or without chemotherapy. The prognosis for patients with such tumors is grim, the median duration of survival being less than 2 years with conventional therapy and the 5-year survival being less than 5%.

Entities:  

Mesh:

Year:  1989        PMID: 2677529     DOI: 10.1016/s0025-6196(12)61228-2

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  20 in total

1.  Primary central nervous system lymphoma and subcutaneous metastases.

Authors:  B Al Bahrani; C Henderson; G Delaney
Journal:  J Neurooncol       Date:  2000-04       Impact factor: 4.130

2.  FDG-PET in immunocompetent patients with primary central nervous system lymphoma: correlation with MRI and clinical follow-up.

Authors:  H Palmedo; H Urbach; H Bender; U Schlegel; I G H Schmidt-Wolf; A Matthies; M Linnebank; A Joe; J Bucerius; H-J Biersack; H Pels
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-10-12       Impact factor: 9.236

3.  Small B-cell lymphoma presenting as diffuse dural thickening with cranial neuropathies.

Authors:  Miguel Estevez; Charleen Chu; Misha Pless
Journal:  J Neurooncol       Date:  2002-09       Impact factor: 4.130

Review 4.  Intradural spinal tumors: current classification and MRI features.

Authors:  Kasim Abul-Kasim; Majda M Thurnher; Paul McKeever; Pia C Sundgren
Journal:  Neuroradiology       Date:  2007-12-15       Impact factor: 2.804

5.  Nonenhancing primary central nervous system lymphoma.

Authors:  S Terae; A Ogata
Journal:  Neuroradiology       Date:  1996-01       Impact factor: 2.804

Review 6.  Primary central nervous system lymphoma.

Authors:  W S Velasquez
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 7.  Primary central nervous system lymphomas--an update.

Authors:  K A Jellinger; W Paulus
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

8.  Occult systemic non-Hodgkin's lymphoma (NHL) in patients initially diagnosed as primary central nervous system lymphoma (PCNSL): how much staging is enough?

Authors:  B P O'Neill; R P Dinapoli; P J Kurtin; T M Habermann
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

9.  Primary cerebral lymphoma: a study of 47 cases probed for Epstein-Barr virus genome.

Authors:  J F Geddes; M B Bhattacharjee; K Savage; F Scaravilli; J E McLaughlin
Journal:  J Clin Pathol       Date:  1992-07       Impact factor: 3.411

Review 10.  Primary brain lymphoma. A brief review of clinical aspects and management.

Authors:  K Sharma; N Rastogi; R Srivastva; V K Jain; S Hukku
Journal:  Neurosurg Rev       Date:  1995       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.